ImmunityBio (IBRX) Equity Ratio (2014 - 2026)
ImmunityBio (IBRX) reported Equity Ratio of 1.34 for Q1 2026, up 30.86% year-over-year from 1.03 in Q1 2025, and down 34.79% on a QoQ basis from 1.0 in Q4 2025.
ImmunityBio (IBRX) has 13 years of Equity Ratio data on file, last reported at 1.34 in Q1 2026.
- Quarterly Equity Ratio rose 30.86% year-over-year to 1.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.34 (up 30.86% YoY) and the FY2025 annual result came in at 1.0, up 21.77% from the prior year.
- Equity Ratio declined to 1.34 in Q1 2026 per IBRX's latest filing, from 1.0 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.87 in Q1 2022 and bottomed at 2.22 in Q2 2023.
- The 5-year median for Equity Ratio is 1.33 (2022), against an average of 1.4.
- The widest annual swing landed in 2022, when Equity Ratio plunged 138.65%; it then soared 50.59% in 2025.
- Tracing IBRX's Equity Ratio over 5 years: stood at 1.24 in 2022, then advanced by 6.43% to 1.16 in 2023, then retreated by 9.74% to 1.27 in 2024, then grew by 21.77% to 1.0 in 2025, then tumbled by 34.79% to 1.34 in 2026.
- Per Business Quant, the three latest IBRX Equity Ratio figures stand at 1.34 (Q1 2026), 1.0 (Q4 2025), and 1.01 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -1.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.34 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | -1.01 |
| Jun 30, 2025 | -1.42 |
| Mar 31, 2025 | -1.94 |
| Dec 31, 2024 | -1.27 |
| Sep 30, 2024 | -2.04 |
| Jun 30, 2024 | -1.57 |
| Mar 31, 2024 | -1.72 |
| Dec 31, 2023 | -1.16 |
| Sep 30, 2023 | -0.95 |
| Jun 30, 2023 | -2.22 |
| Mar 31, 2023 | -1.55 |
| Dec 31, 2022 | -1.24 |
| Sep 30, 2022 | -1.22 |
| Jun 30, 2022 | -1.33 |
| Mar 31, 2022 | -0.87 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | -0.89 |
| Jun 30, 2021 | -0.64 |
| Mar 31, 2021 | -0.88 |
| Dec 31, 2020 | -0.54 |
| Sep 30, 2020 | -0.28 |
| Jun 30, 2020 | 0.07 |
| Mar 31, 2020 | -0.16 |
| Dec 31, 2019 | 0.11 |
| Sep 30, 2019 | 0.85 |
| Jun 30, 2019 | 0.86 |
| Mar 31, 2019 | 0.81 |
| Dec 31, 2018 | 0.45 |
| Sep 30, 2018 | 0.80 |
| Jun 30, 2018 | 0.86 |
| Mar 31, 2018 | 0.87 |
| Dec 31, 2017 | 0.87 |
| Sep 30, 2017 | 0.86 |
| Jun 30, 2017 | 0.84 |
| Mar 31, 2017 | 0.92 |
| Dec 31, 2016 | 0.92 |
| Sep 30, 2016 | 0.94 |
| Jun 30, 2016 | 0.95 |
| Mar 31, 2016 | 0.96 |
| Dec 31, 2015 | 0.97 |
| Sep 30, 2015 | 0.97 |
| Jun 30, 2015 | 0.95 |
| Dec 31, 2014 | 0.96 |